Skip to main content
Erschienen in: Annals of Surgical Oncology 8/2014

01.08.2014 | Gynecologic Oncology

Comparative Patient-Centered Outcomes (Health State and Adverse Sexual Symptoms) Between Adjuvant Brachytherapy Versus No Adjuvant Brachytherapy in Early Stage Endometrial Cancer

verfasst von: Shari Damast, MD, Kaled Alektiar, MD, Anne Eaton, MS, Naamit Kurshan Gerber, MD, Shari Goldfarb, MD, Sujata Patil, PhD, Rachel Jia, MS, Mario Leitao, MD, Jeanne Carter, PhD, Ethan Basch, MD, MSc

Erschienen in: Annals of Surgical Oncology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine a relationship between sexual functioning and health state among survivors of stage I endometrial cancer, and to examine whether adjuvant intravaginal radiotherapy (IVRT) affects these measures compared to hysterectomy alone.

Methods

Two hundred five survivors (>1 year from surgery) completed questionnaires containing the EuroQol (EQ5D) and the Female Sexual Function Index (FSFI). A total of 136 (66.3 %) underwent surgery alone, and 69 (33.7 %) received IVRT. Pearson correlation was used to correlate FSFI and EQ5D–Health State scores. Multivariable regression was performed to measure the impact of IVRT on sexual functioning and health state.

Results

A majority of patients (80 %) met criteria for sexual dysfunction by FSFI < 26.5. A significant correlation was detected between FSFI and EQ5D scores (Pearson correlation = 0.21, p = 0.003). Compared to the IVRT group, the surgery group was younger (p = 0.001) and trended toward more frequent use of minimally invasive surgery versus laparotomy (p = 0.08). Otherwise, the two groups were well balanced with respect to demographics, comorbidities, and baseline sexual activity. Controlling for age and surgery type, IVRT was not associated with poorer health state or sexual function. Receipt of laparotomy was associated with both poorer health state and sexual function (p = 0.0156 and p = 0.0247, respectively).

Conclusions

Sexual functioning was generally poor among endometrial cancer survivors; however, those with improved FSFI scores tended to have superior health states. IVRT was not a significant risk factor; however, receipt of laparotomy appeared to be associated with poorer sexual functioning and health state.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.PubMedCrossRef Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.PubMedCrossRef
2.
Zurück zum Zitat Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404–11.PubMedCrossRef Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404–11.PubMedCrossRef
3.
Zurück zum Zitat Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744–51.PubMedCrossRef Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744–51.PubMedCrossRef
4.
Zurück zum Zitat Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375:816–23.PubMedCrossRef Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375:816–23.PubMedCrossRef
5.
Zurück zum Zitat Nout RA, Putter H, Jurgenliemk-Schulz IM, et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol. 2009;27:3547–56.PubMedCrossRef Nout RA, Putter H, Jurgenliemk-Schulz IM, et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol. 2009;27:3547–56.PubMedCrossRef
6.
Zurück zum Zitat Nout RA, Putter H, Jurgenliemk-Schulz IM, et al. Five-year quality of life of endometrial cancer patients treated in the randomized PORTEC-2 trial and comparison with norm data. Eur J Cancer. 2012;48:1638–48.PubMedCrossRef Nout RA, Putter H, Jurgenliemk-Schulz IM, et al. Five-year quality of life of endometrial cancer patients treated in the randomized PORTEC-2 trial and comparison with norm data. Eur J Cancer. 2012;48:1638–48.PubMedCrossRef
7.
Zurück zum Zitat Sorbe B, Nordstrom B, Maenpaa J, et al. Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer. A controlled randomized study. Int J Gynecol Cancer. 2009;19:873–8.PubMedCrossRef Sorbe B, Nordstrom B, Maenpaa J, et al. Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer. A controlled randomized study. Int J Gynecol Cancer. 2009;19:873–8.PubMedCrossRef
9.
Zurück zum Zitat Pitkin RM, VanVoorhis LW. Post-irradiation vaginitis. An evaluation of prophylaxis with topical estrogen. Radiology. 1971;99:417–21.PubMed Pitkin RM, VanVoorhis LW. Post-irradiation vaginitis. An evaluation of prophylaxis with topical estrogen. Radiology. 1971;99:417–21.PubMed
10.
Zurück zum Zitat Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6:702–13.PubMedCrossRef Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6:702–13.PubMedCrossRef
11.
Zurück zum Zitat Decruze SB, Guthrie D, Magnani R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol. 1999;11:46–8.CrossRef Decruze SB, Guthrie D, Magnani R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol. 1999;11:46–8.CrossRef
12.
Zurück zum Zitat Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys. 1993;27:825–30.PubMedCrossRef Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys. 1993;27:825–30.PubMedCrossRef
13.
Zurück zum Zitat Onujiogu N, Johnson T, Seo S, et al. Survivors of endometrial cancer: who is at risk for sexual dysfunction? Gynecol Oncol. 2011;123:356–9.PubMedCrossRef Onujiogu N, Johnson T, Seo S, et al. Survivors of endometrial cancer: who is at risk for sexual dysfunction? Gynecol Oncol. 2011;123:356–9.PubMedCrossRef
14.
Zurück zum Zitat Becker M, Malafy T, Bossart M, Henne K, Gitsch G, Denschlag D. Quality of life and sexual functioning in endometrial cancer survivors. Gynecol Oncol. 2011;121:169–73.PubMedCrossRef Becker M, Malafy T, Bossart M, Henne K, Gitsch G, Denschlag D. Quality of life and sexual functioning in endometrial cancer survivors. Gynecol Oncol. 2011;121:169–73.PubMedCrossRef
15.
Zurück zum Zitat Quick AM, Seamon LG, Abdel-Rasoul M, Salani R, Martin D. Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial cancer. Int J Gynecol Cancer. 2012;22:703–8.PubMedCentralPubMedCrossRef Quick AM, Seamon LG, Abdel-Rasoul M, Salani R, Martin D. Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial cancer. Int J Gynecol Cancer. 2012;22:703–8.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat The EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef The EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef
17.
Zurück zum Zitat Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.PubMedCrossRef Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.PubMedCrossRef
18.
Zurück zum Zitat Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1–20.PubMedCrossRef Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1–20.PubMedCrossRef
19.
Zurück zum Zitat Goldfarb S, Dickler M, Patil S, et al. Sexual dysfunction in women with breast cancer: prevalence and severity (abstract 30). J Sex Med. 2011;8(Suppl 2):66. Goldfarb S, Dickler M, Patil S, et al. Sexual dysfunction in women with breast cancer: prevalence and severity (abstract 30). J Sex Med. 2011;8(Suppl 2):66.
20.
Zurück zum Zitat Nout RA, van de Poll-Franse LV, Lybeert ML, et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) trial. J Clin Oncol. 2011;29:1692–700.PubMedCrossRef Nout RA, van de Poll-Franse LV, Lybeert ML, et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) trial. J Clin Oncol. 2011;29:1692–700.PubMedCrossRef
21.
Zurück zum Zitat Kornblith AB, Huang HQ, Walker JL, et al. Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol. 2009;27:5337–42.PubMedCentralPubMedCrossRef Kornblith AB, Huang HQ, Walker JL, et al. Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol. 2009;27:5337–42.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Carter J, Huang H, Chase DM, et al. Sexual function of patients with endometrial cancer enrolled in the Gynecologic Oncology Group LAP2 study. Int J Gynecol Cancer. 2012;22:1624–33.PubMedCentralPubMedCrossRef Carter J, Huang H, Chase DM, et al. Sexual function of patients with endometrial cancer enrolled in the Gynecologic Oncology Group LAP2 study. Int J Gynecol Cancer. 2012;22:1624–33.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Verit FF, Verit A, Billurcu N. Low sexual function and its associated risk factors in pre- and postmenopausal women without clinically significant depression. Maturitas. 2009;64:38–42.PubMedCrossRef Verit FF, Verit A, Billurcu N. Low sexual function and its associated risk factors in pre- and postmenopausal women without clinically significant depression. Maturitas. 2009;64:38–42.PubMedCrossRef
24.
Zurück zum Zitat Olarinoye J, Olarinoye A. Determinants of sexual function among women with type 2 diabetes in a Nigerian population. J Sex Med. 2008;5:878–86.PubMedCrossRef Olarinoye J, Olarinoye A. Determinants of sexual function among women with type 2 diabetes in a Nigerian population. J Sex Med. 2008;5:878–86.PubMedCrossRef
25.
Zurück zum Zitat Bayser RE, Li Y, Carter J. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer. 2012;118:4606–18.CrossRef Bayser RE, Li Y, Carter J. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer. 2012;118:4606–18.CrossRef
Metadaten
Titel
Comparative Patient-Centered Outcomes (Health State and Adverse Sexual Symptoms) Between Adjuvant Brachytherapy Versus No Adjuvant Brachytherapy in Early Stage Endometrial Cancer
verfasst von
Shari Damast, MD
Kaled Alektiar, MD
Anne Eaton, MS
Naamit Kurshan Gerber, MD
Shari Goldfarb, MD
Sujata Patil, PhD
Rachel Jia, MS
Mario Leitao, MD
Jeanne Carter, PhD
Ethan Basch, MD, MSc
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 8/2014
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3562-4

Weitere Artikel der Ausgabe 8/2014

Annals of Surgical Oncology 8/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.